FDAHealthDecember 18, 2025
Imprimis NJOF, LLC — Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 713
⚠️ Presence of particulate matter - Glass like particles.
Is this relevant to me?
- Geography
- Nationwide
- Source agency
- FDA
- Category
- Health
- Published
- December 18, 2025
U.S Nationwide
What's affected?
- Product
- Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06.
- Brand
- Imprimis NJOF, LLC
- Lot code
- 25JAN033A
Additional details
Lot: 25JAN033A, 25JAN033B, Expires: 02/12/2026.
What should I do?
Recommended action
Class II recall. Voluntary: Firm initiated Quantity affected: 314 boxes of 6,280 pre-filled syringes.
Get Health recall alerts
Delivered to your inbox. Free. No account required.